Evidence map›Paper›PMID 42225811›Full record

ArticleScientific reports2026

Influence of nicotine concentration and flavours on mouth level exposure and puffing topography among regular e-cigarette consumers in New Zealand.

Lauren Edward, Krishna Prasad, Linsey E Haswell, Adam Gray, Tahseen Jilani, Stacy Fiebelkorn

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lauren EdwardBAT (Investments) Limited, Regents Park Road, Millbrook, Southampton, SO15 8TL, UK. Lauren_Edward@bat.com.
Krishna PrasadBAT (Investments) Limited, Regents Park Road, Millbrook, Southampton, SO15 8TL, UK.
Linsey E HaswellBAT (Investments) Limited, Regents Park Road, Millbrook, Southampton, SO15 8TL, UK.
Adam GrayBAT (Investments) Limited, Regents Park Road, Millbrook, Southampton, SO15 8TL, UK.
Tahseen JilaniBAT (Investments) Limited, Regents Park Road, Millbrook, Southampton, SO15 8TL, UK.
Stacy FiebelkornBAT (Investments) Limited, Regents Park Road, Millbrook, Southampton, SO15 8TL, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

E-cigarette aerosols have substantially reduced toxicant profiles relative to cigarette smoke. Consumers' actual exposure is influenced by the way in which they use these products. We have assessed whether consumer puffing topography (e.g., puff duration, volume and frequency), mouth level exposure (MLE) to nicotine and aerosol, or average daily consumption (ADC) are affected by nicotine concentration or flavour. The study was conducted in New Zealand in 2023 among 90 adult e-cigarette users. Puffing topography and MLE were measured for eight e-liquid variants (five nicotine levels, four flavours) in (1) 15-minute vaping sessions during central location testing (CLT); and (2) 7-day home use testing (HUT). The CLT estimated MLE to nicotine increased with increasing concentration of nicotine, while MLE to aerosol decreased, puff duration decreased and interpuff interval increased, indicating that users alter puffing behaviour to achieve a preferred level of nicotine. Results from the HUT supported these findings. In CLT, less acceptable flavours (e.g., Golden Tobacco) led to significantly fewer puffs of shorter duration compared with more acceptable flavours (e.g., Crisp Mint and Tropical Mango). When the participants used their preferred flavour in HUT, there were no differences in MLE per day or ADC among flavours. E-cigarette users maintain a preferred level of nicotine exposure per day by altering the duration and number of puffs taken in response to nicotine concentration. Overall liking of a flavour is likely to be important in providing a satisfactory alternative to continued smoking for smokers who would not otherwise quit.

Indexed as

Electronic Nicotine Delivery SystemsFlavoring AgentsMouthNicotineVapingAdultAerosolsFemaleHumansMaleMiddle AgedNew ZealandYoung AdultAerosolsFlavoring AgentsNicotineAverage daily consumption (ADC)BridgingElectronic cigaretteElectronic nicotine delivery systemENDSMouth level exposure (MLE)Puffing topographyUse behaviourVuse

Identifiers

PMID42225811
PMCPMC13457872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.